Latest News

Glenmark Pharmaceuticals has got USFDA’s approval for rosuvastatin calcium tablets

The US health regulator USFDA has provided its final approval to the Glenmark Pharmaceuticals for rosuvastatin calcium tablets that are used in lowering cholestrol.

It has said in a BSE filing that “Glenmark Pharmaceuticals Inc, USA has been granted final approval by the US Food and Drug Administration (US FDA) for rosuvastatin calcium tablets.”

Crestor is used for lowering cholesterol and fats (triglycerides) in the blood and is used for reducing the chances of developing problems such as heart disease and strokes.

Read EquityPandit’s Technical Analysis on Nifty PharmaΒ 

Click here to check market prediction for next trading session.

Get Daily Prediction & Stocks Tips On Your Mobile


I would like to receive communication from EquityPandit via sms, email, whatsapp, Google RCS for offers, updates etc.



πŸ“°
News
πŸ“ˆ
Prediction
πŸ“Š
FII / DII
πŸ‘”
Advisory
Get 1-2 Index Option Trades Daily